Refine
Has Fulltext
- yes (24)
Is part of the Bibliography
- yes (24)
Year of publication
Document Type
- Journal article (24)
Language
- English (24) (remove)
Keywords
- Physiologische Chemie (6)
- DNA methylation (5)
- STR profile (2)
- copy number variation (2)
- epigenetics (2)
- extracellular matrix (2)
- fibrosis (2)
- hearing loss (2)
- hepatic stellate cell (2)
- liver (2)
- myofibroblast (2)
- reproductive success (2)
- (classical and atypical) Werner syndrome (1)
- 5-methylcytosine (1)
- Amazon Molly (1)
- Autism (1)
- Autism spectrum disorders (1)
- Copy number variation (1)
- DNA damage (1)
- DNA fingerprinting (1)
- DNA methylation dynamics (1)
- Down syndrome (1)
- Duchenne muscular dystrophy (1)
- Environment (1)
- Epigenetics (1)
- Familial Beckwith-Wiedemann syndrome (1)
- Fetal brain development (1)
- Frontal cortex (1)
- Gene-expression (1)
- Genome (1)
- Genotype-phenotype association (1)
- Human prefrontal cortex (1)
- Lebendgebärende Zahnkarpfen (1)
- Methylome (1)
- Pakistan (1)
- Parent-of-origin (1)
- Patterns (1)
- Perugia-Kärpfling (1)
- Poeciliid fish (1)
- SKY analysis (1)
- SNP array (1)
- SNP-microarray (1)
- Schizophrenia (1)
- Terminal 4q deletion syndrome (1)
- Transcription (1)
- Y chromosome degeneration (1)
- adenoma (1)
- alu elements (1)
- androgen-induced masculinization (1)
- apoptosis (1)
- bisulfite pyrosequencing (1)
- cancer treatment (1)
- chromosome inversion (1)
- complex disorders (1)
- consanguinity (1)
- duplication-deficiency (1)
- dystrophin (1)
- embryos (1)
- exome sequencing (1)
- fetal brain development (1)
- fetal cord blood (1)
- fetal programming (1)
- fibroblasts (1)
- frontal cortex (1)
- genetic causes of cancer (1)
- genetic diagnosis (1)
- genetic diagnostics (1)
- genetic heterogeneity (1)
- genetics (1)
- genome-wide association study (GWAS) (1)
- genome-wide linkage analysis (1)
- genomic imprinting (1)
- genotyping arrays (1)
- gestational diabetes mellitus (1)
- gonads (1)
- gynogeaesls (1)
- hereditary hearing loss (1)
- heterochromatin (1)
- histological subtype (1)
- illumina (1)
- in vitro model (1)
- infinium HumanOmni1-Quad (1)
- insulin treatment (1)
- male size polymorphism (1)
- meiosis (1)
- methylation (1)
- methylation array (1)
- next generation sequencing (1)
- next-generation sequencing (1)
- oocytes (1)
- phalloidin stain (1)
- premature aging (1)
- protocadherin gamma cluster (1)
- reciprocal translocation (1)
- recombination (1)
- recurrence (1)
- rhodamine–phalloidin stain (1)
- segmental progeria (1)
- sex chromosomes (1)
- sex linked pigmentation pattern (1)
- sexual antagonistic genes (1)
- sexual selection (1)
- simple repeat sequences (1)
- simple repetitive sequences (1)
- size polymorpbism (1)
- sodal domlnance (1)
- spectral karyotyping (1)
- sperm (1)
- stress fibers (1)
- submicroscopic chromosome rearrangement (1)
- synaptonemal complex (1)
- testes (1)
- testosterone (1)
- tinnitus (1)
- transcription deficiency (1)
- trisomy 21 (1)
- twin study (1)
- whole genome sequencing (1)
- zebrafish (1)
Institute
- Institut für Humangenetik (16)
- Theodor-Boveri-Institut für Biowissenschaften (15)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (1)
Sonstige beteiligte Institutionen
Normal human brain development is dependent on highly dynamic epigenetic processes for spatial and temporal gene regulation. Recent work identified wide-spread changes in DNA methylation during fetal brain development. We profiled CpG methylation in frontal cortex of 27 fetuses from gestational weeks 12-42, using Illumina 450K methylation arrays. Sites showing genome-wide significant correlation with gestational age were compared to a publicly available data set from gestational weeks 3-26. Altogether, we identified 2016 matching developmentally regulated differentially methylated positions (m-dDMPs): 1767 m-dDMPs were hypermethylated and 1149 hypomethylated during fetal development. M-dDMPs are underrepresented in CpG islands and gene promoters, and enriched in gene bodies. They appear to cluster in certain chromosome regions. M-dDMPs are significantly enriched in autism-associated genes and CpGs. Our results promote the idea that reduced methylation dynamics during fetal brain development may predispose to autism. In addition, m-dDMPs are enriched in genes with human-specific brain expression patterns and/or histone modifications. Collectively, we defined a subset of dDMPs exhibiting constant methylation changes from early to late pregnancy. The same epigenetic mechanisms involving methylation changes in cis-regulatory regions may have been adopted for human brain evolution and ontogeny.
Objectives:
Despite recent advancements in diagnostic tools, the genomic landscape of hereditary hearing loss remains largely uncharacterized. One strategy to understand genome-wide aberrations includes the analysis of copy number variation that can be mapped using SNP-microarray technology. A growing collection of literature has begun to uncover the importance of copy number variation in hereditary hearing loss. This pilot study underpins a larger effort that involves the stage-wise analysis of hearing loss patients, many of whom have advanced to high-throughput sequencing analysis.
Data description:
Our data originate from the Infinium HumanOmni1-Quad v1.0 SNP-microarrays (Illumina) that provide useful markers for genome-wide association studies and copy number variation analysis. This dataset comprises a cohort of 108 individuals (99 with hearing loss, 9 normal hearing family members) for the purpose of understanding the genetic contribution of copy number variations to hereditary hearing loss. These anonymized SNP-microarray data have been uploaded to the NCBI Gene Expression Omnibus and are intended to benefit other investigators interested in aggregating platform-matched array patient datasets or as part of a supporting reference tool for other laboratories to better understand recurring copy number variations in other genetic disorders.
Tinnitus is the perception of a phantom sound that affects between 10 and 15% of the general population. Despite this considerable prevalence, treatments for tinnitus are presently lacking. Tinnitus exhibits a diverse array of recognized risk factors and extreme clinical heterogeneity. Furthermore, it can involve an unknown number of auditory and non-auditory networks and molecular pathways. This complex combination has hampered advancements in the field. The identification of specific genetic factors has been at the forefront of several research investigations in the past decade. Nine studies have examined genes in a case-control association approach. Recently, a genome-wide association study has highlighted several potentially significant pathways that are implicated in tinnitus. Two twin studies have calculated a moderate heritability for tinnitus and disclosed a greater concordance rate in monozygotic twins compared to dizygotic twins. Despite the more recent data alluding to genetic factors in tinnitus, a strong association with any specific genetic locus is lacking and a genetic study with sufficient statistical power has yet to be designed. Future research endeavors must overcome the many inherent limitations in previous study designs. This review summarizes the previously embarked upon tinnitus genetic investigations and summarizes the hurdles that have been encountered. The identification of candidate genes responsible for tinnitus may afford gene based diagnostic approaches, effective therapy development, and personalized therapeutic intervention.
Background
Dystrophinopathies caused by variants in the DMD gene are a well‐studied muscle disease. The most common type of variant in DMD are large deletions. Very rarely reported forms of variants are chromosomal translocations, inversions and deep intronic variants (DIVs) because they are not detectable by standard diagnostic techniques (sequencing of coding sequence, copy number variant detection). This might be the reason that some clinically and histologically proven dystrophinopathy cases remain unsolved.
Methods
We used whole genome sequencing (WGS) to screen the entire DMD gene for variants in one of two brothers suffering from typical muscular dystrophy with strongly elevated creatine kinase levels.
Results
Although a pathogenic DIV could not be detected, we were able to identify a pericentric inversion with breakpoints in DMD intron 44 and Xq13.3, which could be confirmed by Sanger sequencing in the index as well as in his brother and mother. As this variation affects a major part of DMD it is most likely disease causing.
Conclusion
Our findings elucidate that WGS is capable of detecting large structural rearrangements and might be suitable for the genetic diagnostics of dystrophinopathies in the future. In particular, inversions might be a more frequent cause for dystrophinopathies as anticipated and should be considered in genetically unsolved dystrophinopathy cases.